Trial Profile
Study of patients with relapsed/refractory diffuse large B-cell lymphoma treated with R-ICE based on dual expression of MYC and BCL2
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2016
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Etoposide (Primary) ; Ifosfamide (Primary) ; Rituximab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 03 Aug 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology